March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
In Vitro Proliferative Response Of Human Tenons And Scleral Cells From Patients Undergoing Glaucoma Filtration Surgery- A Clinical Correlation
Author Affiliations & Notes
  • Karunakaran Coral
    Dept of Biochemistry & Cell Biology, Vision Research Foundation, Sankara Nethralaya, Chennai, India
  • Jagaveerapandiyan Sarangapani
    Dept of Biochemistry & Cell Biology, Vision Research Foundation, Sankara Nethralaya, Chennai, India
  • Vineet Ratra
    Smt Jadhavbai Nathmal Singhvee Glaucoma Services, Medical Research Foundation, Sankara Nethralaya, Chennai, India
  • Sulochana KN
    Dept of Biochemistry & Cell Biology, Vision Research Foundation, Sankara Nethralaya, Chennai, India
  • Footnotes
    Commercial Relationships  Karunakaran Coral, None; Jagaveerapandiyan Sarangapani, None; Vineet Ratra, None; Sulochana Kn, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 3870. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Karunakaran Coral, Jagaveerapandiyan Sarangapani, Vineet Ratra, Sulochana KN; In Vitro Proliferative Response Of Human Tenons And Scleral Cells From Patients Undergoing Glaucoma Filtration Surgery- A Clinical Correlation. Invest. Ophthalmol. Vis. Sci. 2012;53(14):3870.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Glaucoma is an optic neuropathy characterized by optic disc changes and corresponding visual field defects in which intra ocular pressure (IOP) is the only treatable factor. Failure of trabeculectomy surgery is due to excessive scarring in sclera and subconjunctiva. The purpose of this study is to look at the proliferative response of the sclera and tenons tissues removed from patients undergoing trabeculectomy surgery and also to screen the effect of compounds which inhibit excess wound healing.

Methods: : The study was approved by the Ethics committee of the Institute and informed consent were obtained from patients. Detailed clinical proforma was filled. Scleral tissues (n=8) and tenons (n=7) removed surgically from patients undergoing trabeculectomy was processed for cell culture. The clinical outcome of the patients after surgery was assessed.The tissues were treated with 0.2 % collagenase and plated on 0.1 % gelatin coated dishes with EGM medium. The isolated cells were identified using specific markers viz Fibroblast specific protein (FSP) for human tenons fibroblast (HTF) and SOX9 for human scleral cells (HSC) by RT-PCR. Wound healing was done by scratch assay in cells using drugs like mitomycin C (MMC) and cyclosporine A (CsA) at concentrations of 10 ng to 100 μg/ml and endogenous extracellular matrix derived peptides at concentrations of 10 to 100 µM.

Results: : Sclera and tenons tissues from patients (n=2) who had post operatively corkscrew vessels on the bleb which is suggestive of increased scarring grew in vitro.These cells grew after 5-7 days and the confluent cells showed typical cell specific morphology. mRNA expression of HSC were positive for SOX 9 (213bp) and HTF were positive for FSP (153bp) by RT-PCR. Wound healing as evaluated by scratch assay showed inhibition of cell migration with a combination of MMC (100 μg/ml ie 300 μM) and CsA (50 μg/ml ie 40 μM) compared to MMC alone. Extracellular matrix derived peptides were effective in inhibiting cell migration at 10 μM concentration. No cytotoxicity was observed for these compounds at the tested concentrations by MTT assay.

Conclusions: : In vitro cell growth of sclera and tenons could be a predictive marker for the poor outcome of glaucoma filtration surgery, such cases could be treated with endogenous extracellular matrix derived peptides which inhibit cell migration thereby preventing scar formation.

Keywords: extracellular matrix • wound healing • proliferation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×